Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis
- PMID: 27723141
- PMCID: PMC5386838
- DOI: 10.1002/jcp.25638
Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis
Abstract
DC-STAMP is a multi-pass transmembrane protein essential for cell-cell fusion between osteoclast precursors during osteoclast (OC) development. DC-STAMP-/- mice have mild osteopetrosis and form mononuclear cells with limited resorption capacity. The identification of an Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) on the cytoplasmic tail of DC-STAMP suggested a potential signaling function. The absence of a known DC-STAMP ligand, however, has hindered the elucidation of downstream signaling pathways. To address this problem, we engineered a light-activatable DC-STAMP chimeric molecule in which light exposure mimics ligand engagement that can be traced by downstream Ca2+ signaling. Deletion of the cytoplasmic ITIM resulted in a significant elevation in the amplitude and duration of intracellular Ca2+ flux. Decreased NFATc1 expression in DC-STAMP-/- cells was restored by DC-STAMP over-expression. Multiple biological phenotypes including cell-cell fusion, bone erosion, cell mobility, DC-STAMP cell surface distribution, and NFATc1 nuclear translocation were altered by deletion of the ITIM and adjacent amino acids. In contrast, mutations on each of the tyrosine residues surrounding the ITIM showed no effect on DC-STAMP function. Collectively, our results suggest that the ITIM on DC-STAMP is a functional motif that regulates osteoclast differentiation through the NFATc1/Ca2+ axis. J. Cell. Physiol. 232: 2538-2549, 2017. © 2016 Wiley Periodicals, Inc.
© 2016 Wiley Periodicals, Inc.
Conflict of interest statement
The authors have no conflicts for this manuscript.
Figures
F409; mut#2: Y409
A409) were introduced in the ITIM.
F409; mut#2: Y409
A409) were introduced in the ITIM.
F409 or
A409, j-l), or vector (a-c). After viral infection, cells were cultured in OC-promoting media (RANKL and M-CSF). 1st column: TRAP staining (a,d,g,j); 2nd column: GFP fluorescent images (b,e,h,k); 3rd column: bone wafer assay (c,f,i,l). Red asterisks identify selected erosion pits. (B) Summary of results shown in (A). (a) Number of nuclei per OC, (b) surface area per OC, (c) surface area per erosion pit. (***P=0.001; **P=0.01).
F409 or
A409, j-l), or vector (a-c). After viral infection, cells were cultured in OC-promoting media (RANKL and M-CSF). 1st column: TRAP staining (a,d,g,j); 2nd column: GFP fluorescent images (b,e,h,k); 3rd column: bone wafer assay (c,f,i,l). Red asterisks identify selected erosion pits. (B) Summary of results shown in (A). (a) Number of nuclei per OC, (b) surface area per OC, (c) surface area per erosion pit. (***P=0.001; **P=0.01).
button to start each video. Ca2+ pulses are labeled with black asterisks, and the arrows close to the spikes indicate the trend of Ca2+ signal strength. (C) Fold change of intracellular Ca2+ flux before (a) and after (b) light activation on 293T cells transfected with vector, WT-, or –TD-PA-DCSTAMP. A significant difference in Ca2+ flux was detected between the ITIM-deleted PA mutant and vector control (mean +/− SEM; * P ≤ 0.05). (D) Percentage of WT- and TD- DCSTAMP-expressing 293T cells that showed Ca2+ flux after light activation. * P ≤ 0.05. (E) Duration time of intracellular Ca2+ signals after light activation in WT-, TD-DCSTAMP, & vector- transfected 293T cells. *P ≤ 0.05.
button to start each video. Ca2+ pulses are labeled with black asterisks, and the arrows close to the spikes indicate the trend of Ca2+ signal strength. (C) Fold change of intracellular Ca2+ flux before (a) and after (b) light activation on 293T cells transfected with vector, WT-, or –TD-PA-DCSTAMP. A significant difference in Ca2+ flux was detected between the ITIM-deleted PA mutant and vector control (mean +/− SEM; * P ≤ 0.05). (D) Percentage of WT- and TD- DCSTAMP-expressing 293T cells that showed Ca2+ flux after light activation. * P ≤ 0.05. (E) Duration time of intracellular Ca2+ signals after light activation in WT-, TD-DCSTAMP, & vector- transfected 293T cells. *P ≤ 0.05.Similar articles
-
The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity.Mod Rheumatol. 2006;16(6):341-2. doi: 10.1007/s10165-006-0524-0. Epub 2006 Dec 20. Mod Rheumatol. 2006. PMID: 17164993 Review.
-
NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).Mol Endocrinol. 2008 Jan;22(1):176-85. doi: 10.1210/me.2007-0237. Epub 2007 Sep 20. Mol Endocrinol. 2008. PMID: 17885208 Free PMC article.
-
MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.Biochim Biophys Acta. 2014 Nov;1839(11):1084-96. doi: 10.1016/j.bbagrm.2014.08.002. Epub 2014 Aug 11. Biochim Biophys Acta. 2014. PMID: 25123438
-
Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.J Bone Miner Res. 2007 Jul;22(7):992-1001. doi: 10.1359/jbmr.070401. J Bone Miner Res. 2007. PMID: 17402846
-
DC-STAMP: A Key Regulator in Osteoclast Differentiation.J Cell Physiol. 2016 Nov;231(11):2402-7. doi: 10.1002/jcp.25389. Epub 2016 Jun 14. J Cell Physiol. 2016. PMID: 27018136 Free PMC article. Review.
Cited by
-
A novel method to efficiently differentiate human osteoclasts from blood-derived monocytes.Biol Proced Online. 2024 Mar 19;26(1):7. doi: 10.1186/s12575-024-00233-6. Biol Proced Online. 2024. PMID: 38504200 Free PMC article.
-
D-Mannose prevents bone loss under weightlessness.J Transl Med. 2023 Jan 9;21(1):8. doi: 10.1186/s12967-022-03870-1. J Transl Med. 2023. PMID: 36617569 Free PMC article.
-
Green tea polyphenol EGCg induces cell fusion via reactive oxygen species.Biochem Biophys Rep. 2023 Aug 30;35:101536. doi: 10.1016/j.bbrep.2023.101536. eCollection 2023 Sep. Biochem Biophys Rep. 2023. PMID: 37680558 Free PMC article.
-
The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption.Front Endocrinol (Lausanne). 2022 May 18;13:885507. doi: 10.3389/fendo.2022.885507. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35663327 Free PMC article.
-
Conserved sperm factors are no longer a bone of contention.Elife. 2021 Apr 28;10:e68976. doi: 10.7554/eLife.68976. Elife. 2021. PMID: 33908866 Free PMC article.
References
-
- Albagha OM, Wani SE, Visconti MR, Alonso N, Goodman K, Brandi ML, Cundy T, Chung PY, Dargie R, Devogelaer JP, Falchetti A, Fraser WD, Gennari L, Gianfrancesco F, Hooper MJ, Van Hul W, Isaia G, Nicholson GC, Nuti R, Papapoulos S, Montes Jdel P, Ratajczak T, Rea SL, Rendina D, Gonzalez-Sarmiento R, Di Stefano M, Ward LC, Walsh JP, Ralston SH Genetic Determinants of Paget's Disease C. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet. 2011;43(7):685–689. - PubMed
-
- Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007;40(2):251–264. - PubMed
-
- Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, Cella M, Kim T, Rho J, Negishi-Koga T, Delaisse JM, Takayanagi H, Lorenzo J, Colonna M, Farndale RW, Choi Y, Trowsdale J. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest. 2011;121(9):3505–3516. - PMC - PubMed
-
- Beauregard M, Gagnon E, Guay-Belanger S, Morissette J, Brown JP, Michou L. Identification of rare genetic variants in novel loci associated with Paget's disease of bone. Hum Genet. 2014;133(6):755–768. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
